{"prompt": "['OSTPDL1', 'St. Jude', 'OSTPDL1', 'Initial version, dated: 07-29-2016. Resubmitted to CT-SRC 09-27-2016.', 'Resubmitted to IRB 10-21-2016 and 11-16-2016 (IRB approved: 12-13-2016)', 'Activated: January 3, 2017', 'Amendment 1.0, dated: 04-06-2017 (IRB approved: 05-09-2017)', 'Activated: June 16, 2017', 'Revision 1.1, dated 01-19-2018 (IRB approved: 01-26-2018)', 'Activated:', 'A PHASE II TRIAL OF AVELUMAB, A FULLY HUMAN ANTIBODY THAT', 'TARGETS CELLS EXPRESSING PD-L1 IN PATIENTS WITH RECURRENT OR', 'PROGRESSIVE OSTEOSARCOMA', 'IND# 132,874 (sponsor: St. Jude)', 'Principal Investigator', 'Michael W. Bishop, MD, MS', 'Department of Oncology', 'Solid Tumor Division', 'St. Jude Sub-Investigators', 'Alberto S. Pappo, MD', 'Paul Thomas, PhD', 'Department of Oncology', 'Benjamin Youngblood, PhD', 'Solid Tumor Division', 'Department of Immunology', 'Deo Kumar Srivastava, PhD', 'Sue Kaste, DO', 'Guolian Kang, PhD', 'Michael Doubrovin, MD, PhD', 'Zhaohua Lu, PhD', 'Department of Diagnostic Imaging', 'Department of Biostatistics', 'Jennifer L. Harman, PhD', 'Department of Psychology', \"St. Jude Children's Research Hospital\", '262 Danny Thomas Place', 'Memphis, Tennessee 38105-3678', 'Telephone: (901)595-3300', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: 01-26-201 APPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']['OSTPDL1', 'Contents of this document may not be extracted without permission from the Principal', 'Investigator', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: 01-26-p81&PPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']['OSTPDL1', 'List of Collaborating Investigators/Institutions', 'Contact Information', 'Leo Mascarenhas, MD, MS', 'Sarah B. Whittle, MD', 'Lee J. Helman, M.D.', 'Lisa L. Wang, MD', 'Keck School of Medicine', 'Nino Rainusso, MD', 'University of Southern California', \"Texas Children's Cancer Center\", \"Children's Hospital Los Angeles\", 'Baylor College of Medicine', '4650 Sunset Blvd', '1102 Bates Street, Suite 1240.12', 'Mail Stop 57', 'Houston, TX', 'Los Angeles, CA 90027', 'Ph: 832-824-4822', 'Ph: 323-361-6058', 'sbwhittl@txch.org', 'Imascarenhas@chla.usc.edu', 'llwang@txch.org', 'lhelman@chla.usc.edu', 'ncrainuss@txch.org', 'James L. Gulley, M.D., Ph.D.', 'Filemon Dela Cruz, MD', 'Center for Cancer Research', 'Paul A. Meyers, MD', 'National Cancer Institute', 'Alexander J Chou, MD', 'Building 10, Room 12N226', 'Memorial Sloan Kettering Cancer', 'Bethesda, MD 20892-1750', 'Center', 'Ph: 301-435-2956', '1275 York Ave #1408', 'gulleyj@mail.nih.gov', 'New York, NY 10065', '212-639-5952', 'Jeffrey Schlom, PhD', 'delacrf1@mskcc.org', 'Caroline Jochems, MD, PhD', 'meyersp@mskcc.org', 'Renee Donahue, PhD', 'choua@mskcc.org', 'Laboratory of Tumor Immunology and', 'Biology', 'Center for Cancer Research', 'National Cancer Institute', 'Building 10, Room 8B09', 'Bethesda, MD 20892-1750', 'Ph: 301-496-4343', 'js141@nih.gov', 'St. Jude', 'IRB NUMBER: Pro00006856', 'Revision 1.1, dated: 01-19-2018', 'IRB approved: 01-26-3018 APPROVAL DATE: 06/26/2019', 'Protocol document dated: 01-19-2018']\n\n###\n\n", "completion": "END"}